RA Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $17.2M | Hold |
|
|||||
|
2024
Q4 | $23.7M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $19.4M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $26.9M | Hold |
|
|||||
|
2023
Q2 | $29.3M | Hold |
|
|||||
|
2023
Q1 | $9.91M | Hold |
|
|||||
|
2022
Q4 | $11.8M | Hold |
|
|||||
|
2022
Q3 | $26.7M | Hold |
|
|||||
|
2022
Q2 | $26.5M | Hold |
|
|||||
|
2022
Q1 | $41M | Hold |
|
|||||
|
2021
Q4 | $41.3M | Buy |
|
|||||
|
2021
Q3 | $23M | Buy |
|
|||||
|
2021
Q2 | $11.2M | Hold |
|
|||||
|
2021
Q1 | $12.7M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $11.1M | Hold |
|
|||||
|
2014
Q1 | $10.5M | Buy |
|
|||||
|
2013
Q4 | $4.71M | Buy |
|